How many insider declarations has Saxena Nishant C filed?

Saxena Nishant C has filed 2 public insider declarations with SEC (Form 4).

What is Saxena Nishant C's role?

Saxena Nishant C's reported role is not specified by the regulator across the filings.

Which companies does Saxena Nishant C report trades for?

Saxena Nishant C reports trades for Corbus Pharmaceuticals Holdings, Inc..

What is Saxena Nishant C's declared buy vs sell volume?

Across the available history, declared buys total 22k€ and disposals 0.

← Executives ★ Sign in to follow

SN

Saxena Nishant C

OFFICER

·SEC (Form 4)

Corbus Pharmaceuticals Holdings, Inc.

0

申报总数

0

公司

€21,674

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the full record of transactions filed by Saxena Nishant C. Director active across 1 company, notably Corbus Pharmaceuticals Holdings, Inc.. Aggregated, 2 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €22k. History available since 21 May 2026. The latest transaction was filed on 11 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Saxena Nishant C

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Corbus Pharmaceuticals Holdings, Inc. (US)

申报2 总计

▲

Saxena Nishant C

Chief Business Officer高管2026年8月11日Corbus Pharmaceuticals Holdings, Inc.

US$25,03630SEC ↗

2,600 股@ US$9.62940.0011% mcap100.0% 占其流量Common Stock, par value $0.0001 per shareSEC:0001193125-26-346966:0

标准退出：2026年11月9日 (T+90)

◆

Saxena Nishant C

Chief Business Officer高管2026年5月21日Corbus Pharmaceuticals Holdings, Inc.

0SEC ↗

58,300 股0Common Stock, par value $0.0001 per shareSEC:0001193125-26-237103:0

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

SN

Saxena Nishant C

OFFICER

·SEC (Form 4)

Corbus Pharmaceuticals Holdings, Inc.

0

申报总数

0

公司

€21,674

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the full record of transactions filed by Saxena Nishant C. Director active across 1 company, notably Corbus Pharmaceuticals Holdings, Inc.. Aggregated, 2 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €22k. History available since 21 May 2026. The latest transaction was filed on 11 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.